reported on their experiences from dialysers currently used for treating patients for permanent renal failure. Why then have we encountered a different epidemiological pattern for patients who require dialysis for chronic renal failure?
In attempting to answer this question we recalled our previous observations in patients with acute renal failure where a direct relationship between advanced uraemia and severe infection was clearly established.
It seemed logical to consider the effects that the deranged metabolism and nutritional impairment of chronic renal failure have upon the liver, the primary site of attack for this virus (Young and Parsons, 1970a) .
Abnormalities of hepatic metabolism and nutrition
In patients with chronic renal failure undergoing long-term intermittent dialysis, the liver is exposed to an abnormal chemical environment in which the metabolic functions are severely affected. Oxidative phosphorylation (Yamada et al., 1969) , hydroxyproline oxidase (Avioli et al., 1969a) , phenylalanine hydroxylase (Young and Parsons, 1970b) and pseudocholinesterase (Simon et al., 1962) , are all inhibited or impaired in uraemia. Changes in lipid metabolism (Losowsky and Kenward, 1968 ) and increases in protein catabolism (Scholz et al., 1970) have been observed.
There is also some evidence that the supply of certain nutrients to the liver is reduced in renal failure. The availability of folate (Sevitt and Hoffbrand, 1969 ) may be inadequate in some patients and the metabolism of vitamin D, in the liver deranged (Avioli et al., 1969b) .
The supply of amino acids to the liver is necessarily reduced in the presence of low protein diets. Our own observations (Young and Parsons, 1970b) have shown that all patients with chronic renal failure taking at least 40 g of protein per day exhibit an amino acid imbalance resembling that found in humans living on a deficient protein intake, when the creatinine clearance falls below 15 ml/min, a level which includes those patients on intermittent dialysis. The imbalance was most severe in patients with a high plasma creatinine. . clin. Biochem. 8 (1971) 143 Hepatitis in Renal Dialysis Units F. M. PARSONS AND G. A. YOUNG
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Some 13 years ago we became alarmed at the high morbidity and mortality caused by infection in patients who required dialysis for hypercatabolic acute renal failure. After intensive investigation of these patients we came to the conclusion that existing dialysis procedures produced a differential correction of the biochemical abnormalities. By instituting either earlier dialysis or increasing the duration of dialysis a more balanced correction of the biochemical abnormalities was achieved. This so enhanced resistance to bacterial infection (Parsons et al., 1961) that both morbidity and mortality were reduced significantly.
Soon after the introduction of dialysis for permanent renal failure by Dr. Scribner in 1960 (Quinton et al., 1960) outbreaks of viral hepatitis in intermittent dialysis were reported (Lancet, 1965; Ringertz and Melen, 1966; Jones et al., 1967) . The natural history of this new type of hepatitis proved to be unusual for in most infections the microorganism is either eradicated or kills the patient whereas in those patients undergoing treatment by long-term intermittent dialysis a peculiar and previously unrecognised type of carrier state was noted. Since 1965 much has been written about this problem. Besides affecting patients in dialysis units the staff were involved and spread occurred remote from the dialysis unit and involved laboratory workers whose only physical contact with the infected patient was via samples of biological fluid, such as blood, sent for analysis. In their report on regular dialysis treatment in Europe, Drukker et al. (1970) showed that hepatitis occurring in intermittent dialysis units had reached alarming proportions. They reported a total of 390 cases in Europe occurring in the year under review of which 260 occurred in patients and 130 in members of the staff. 2.4 % of deaths in intermittent dialysis units in Europe were caused by viral hepatitis.
This experience was the more surprising for similar outbreaks had not been reported in units that had catered solely for patients with acute renal failure and many of these units had been in existence for at least 20 years even though isolated cases of viral hepatitis had been treated; a possible exception was reported from Manchester in infectious hepatitis (Lancet, 1965) . The fact that cross-infection did not apparently occur is the more remarkable for more Clinical considerations blood was spilled from the older type of haemodialyser, used for acute renal failure, than is spilled 143 on viral hepatitis in a dialysis unit. Three of their patients were described as 'fit' at the time they developed hepatitis and subsequently these patients became hepatitis-associated antigen negative. Those patients on intermittent dialysis who were 'unfit' at the time they developed hepatitis remained AUjSH antigen positive. Even though these patients were subsequently treated by a better haemodialysis programme the patients remained viral-carriers. Our own observations suggest that such 'unfit' patients have abnormalities of a metabolic and nutritional origin as already described. There is some evidence that dietary deficiency alone may play some part. Ruebner and Bramhall (1959) reported that mice fed on a decreased protein intake were more susceptible to their own type of viral hepatitis than those animals fed on a normal diet. However, any such effect may be further enhanced by the metabolic derangements present in uraemia. We have had some evidence of hepatic changes in two of our own patients on long-term intermittent dialysis (4 and 4t years respectively) who died in 1970. One patient had cirrhosis of the liver and this contributed to her death. She had been treated with a Giovannetti type of diet for over a year before beginning intermittent dialysis and it is possible that the development of the cirrhosis was associated with long-term nutritional impairment in addition to any subsequent abnormalities that might have developed when she was placed on intermittent haemodialysis and a protein intake of 50-70 g per day. The other patient who died 4t years after beginning intermittent peritoneal dialysis and received 45 g of protein per day, showed microscopic changes compatible with mild under nutrition. Before death both patients had a disturbance of amino acids of the plasma similar to that found in protein depleted states. A higher incidence of AUjSH positive individuals has also been reported in many patients with hepatic disorders but not associated with renal failure (Prince et al., 1970; Bagshawe et al., 1971) . Although a relationship may seem to be present between the natural history of viral hepatitis in chronic renal failure and associated abnormalities of hepatic function and impaired nutrition there is, as yet, no final proof that the two are intimately connected. However, at the present time a connection between the two seems to offer a more rational explanation than any other so far advanced.
Tentatively we suggest that the sequence of events leading to the spread of hepatitis in renal units may be:-1. The introduction of a virus into a patient being treated in the intermittent dialysis unit, probably as a result of an infected blood transfusion. The presence of a primary metabolic disturbance of the liver alters in some way the usually accepted clinical course of the disease. The known impairment of immunological response in patients with renal failure would also be contributory but not the sole cause. 2. Once a patient has developed hepatitis in a hospital unit then replication of the virus produces either an infection of unusual virulence or degree of viraemia which could be attributable to the impaired hepatic function and nutritional state. The virus is then more likely to spread to other patients or members of staff. 3. In many patients developing hepatitis the disease may follow a relatively benign course and pass into a chronic carrier state (AUjSH positive) which may persist for a long period of time or even be permanent (Knight et al., 1970) . 4. In normal individuals the disease is severe and sometimes fatal although the illness and the presence of the AUjSH antigen is usually of short duration. Whether this hypothesis is correct or not it would seem wise to limit the spread of viral hepatitis by introducing the following prophylactic procedures in a renal unit:-1. Reduce blood transfusion as much as possible. If a patient requires blood transfusion, negative AUjSH tested blood should be given preferably obtained from a carefully selected panel of blood donors.
No patient should be accepted for long-term
intermittent dialysis who has a past history or active signs of viral hepatitis. 3. As far as possible all patients on intermittent dialysis should be transferred to home dialysis once they have been trained in a hospital unit. 4. Intermittent dialysis must be instituted early in the course of progressive renal failure; certainly 'unfit' patients should be excluded and those that have had evidence of protracted nutritional impairment. 5. Under-dialysis must be prevented and perhaps it would be unwise to institute long-term peritoneal dialysis as a staging procedure prior to the introduction of haemodialysis. It may well be that the minimum time of dialysis should be 40 h per week, divided into three or four sessions of equal duration.
PRECAUTIONS
All authors seem to agree that it is the type B or serum hepatitis (long-term incubation viral hepatitis) that is the main hazard in dialysis units. Because the incubation period is long, 60 to 120 days, it would be safe to assume that every patient being treated by intermittent dialysis is potentially capable of transmitting the disease to another person. This means that all other patients being treated by intermittent dialysis in the unit and staff looking after those patients are potentially at risk. Staff, in this context, should be defined as all members of the community likely to come into direct contact with the patient or any sample, such as blood, taken from a patient and sent to a laboratory for investigation. This also means that barbers, dentists and others outside the hospital community are likely to contract the disease from an infected individual as well as the family of those patients being treated by home dialysis (Blumberg and Giger, 1970) .
Let us review briefly the course of events in which cross-infection can take place between a dialysis unit and a laboratory. Much of the danger arises from direct contact with body fluids from the patient. The hands would appear the most vulnerable point of entry through minute abrasions of the skin. It is therefore essential that all staff should wear gloves when they are either in direct physical contact with the patient, or any sample taken from that patient. Other precautions to be instituted would include:-
Request form
The request form that normally accompanies the specimen must be carefully looked after. Documentation of the report form and unused specimen tube must take place outside the dialysis area. After this documentation has been completed the request form should be kept outside the dialysis area whilst the sample is collected from the patient.
It is essential that the dialysis unit use a method whereby the staff of the laboratory can be alerted that a potentially dangerous sample has been sent. We use a red rubber stamp so that the words 'INTERMITTENT DIALYSIS' or 'TRANS-PLANT' are stamped on the request form. As this is an off-standard procedure in our hospital it affords a very convenient way of alerting the receiver. This red rubber stamp should also be used on all request forms for sometimes the patient has to travel to another department for full investigation and, as often as not, a blood sample has to be taken. In many hospitals gummed labels are used to identify a specimen tube. These labels must not be moistened by the tongue.
Handling 0/ sample tube
Any biological sample taken from a patient on intermittent dialysis must be assumed to be potentially dangerous. It is extremely difficult to obtain blood 145 or other biological fluid from the patient without some spillage, or droplet formation, contaminating the outside of the specimen tube. The collected sample should be placed in a polythene bag whilst it is still in the dialysis area. This tube, now inside a sealed polythene bag, should then be transported outside the dialysis area and placed in a second polythene bag which has previously been pushed into a waxed carton, the open end of which has been everted over the outside of the wax carton. Another member of staff, who is wearing clean gloves and who has not been inside the dialysis area, then seals the second polythene bag before it is dispatched to the laboratory accompanied by the previously documented request form. Despite these precautions it is doubtful whether anyone can guarantee complete protection, and human error can always occur, so that it is essential to retain all reasonable precautions during the transport and subsequent analysis.
Design ofcontainer
Ideally, blood sample tubes should be disposable, unbreakable (even in a centrifuge), leakproof and transparent. The stopper requires special attention for on removal, spillage of the contents of the tube by large or minute droplets, which may become airborne, must not occur. None of the tubes currently available that we have examined satisfies all these requirements. It must be remembered that in many investigations it is only the plasma that is required by the laboratory. Great care is thus needed when plasma is separated from the red cells after centrifuging. This procedure has often to be undertaken in the dialysis unit if patients are treated through the night hours. So far we have not been able to devise a simple and safe method for undertaking this procedure.
